In This Episode
In the last 24 hours, the EU has threatened to place export controls on vaccines manufactured in the EU; while a German paper has been corrected by Berlin for misreporting that the German government thought the Oxford-Astrazeneca jab was only eight per cent effective in over-65s. Isabel Hardman talks to Katy Balls and James Forsyth about what’s going on and whether it could impact Britain’s supply.
Comments
A blooming good offer
Join the conversation with other Spectator readers by getting the next 3 months for £3.
CLAIM OFFER 3 months for £3Already a subscriber? Log in